DPP-4 Inhibitors
Author:
Affiliation:
1. Internal Medicine D and Obesity Clinic, Hasharon Hospital, Rabin Medical Center, Tel Aviv University, Tel Aviv, Israel
Publisher
American Diabetes Association
Subject
Advanced and Specialized Nursing,Endocrinology, Diabetes and Metabolism,Internal Medicine
Link
https://diabetesjournals.org/care/article-pdf/34/Supplement_2/S276/609308/s276.pdf
Reference18 articles.
1. Advances in therapy for type 2 diabetes: GLP-1 receptor agonists and DPP-4 inhibitors;Davidson;Cleve Clin J Med,2009
2. Efficacy and safety of incretin therapy in type 2 diabetes: systematic review and meta-analysis;Amori;JAMA,2007
3. Effect of initial combination therapy with sitagliptin, a dipeptidyl peptidase-4 inhibitor, and metformin on glycemic control in patients with type 2 diabetes;Goldstein;Diabetes Care,2007
4. Safety and tolerability of sitagliptin in patients with type 2 diabetes: a pooled analysis;Williams-Herman;BMC Endocr Disord,2008
5. U.S. Food and Drug Administration. Information for healthcare professionals: acute pancreatitis and sitagliptin (marketed as Januvia and Janumet) [Internet], 2009. Available from http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsand Providers/DrugSafetyInformationforHeathcareProfessionals/ucm183764. Accessed 14 January 2010
Cited by 190 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The entero-insular axis and metabolic syndrome;Metabolic Syndrome;2024
2. Effects of dipeptidyl peptidase 4 inhibition on the endothelial control of the vascular tone;American Journal of Physiology-Cell Physiology;2023-10-01
3. Angioedema From Triple Therapy: A Case Report;Cureus;2023-09-30
4. Sitagliptin: the fixed combination of the first dipeptidyl peptidase 4 inhibitor and metformin;Meditsinskiy sovet = Medical Council;2023-08-19
5. Verordnung von Antidiabetika und glykämische Kontrolle bei Erwachsenen mit Diabetes mellitus Typ 2 im zeitlichen Verlauf: Auswertung aus dem DPV-Register aus den Jahren 2005 bis 2021;Diabetologie und Stoffwechsel;2023-06-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3